1.Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease
Shasha ZHANG ; Xiaoyun WAN ; Caiyun ZHOU ; Weiguo Lü ; Xing XIE
Chinese Journal of Obstetrics and Gynecology 2011;46(7):510-515
Objective To investigate the expression of low molecular mass polypeptide-2 (LMP2)and protein phosphatase 1A (PPM1A) in gestational trophoblastic disease and elucidate their predictive value in malignant transformation of hydatidiform mole. Methods The expressions of LMP2 and PPM1A protein in 196 complete hydatidiform moles (in which 28 cases with malignant transformation) , 7 invasive moles, 5 choriocarcinomas and 20 normal chorionic villus were detected with the method of En Vision immunohistochemistry. Their clinicopathologic data were retrospectively analyzed. Results LMP2 and PPM1A protein expressed in cytotrophocytes, syncytiotrophoblast and extravillous trophoblast. The level of LMP2 expression in deteriorative hydatidiform mole was significantly higher than that in non-deteriorative hydatidiform mole or normal chorionic villus (6. 79 ±2. 38, 5.26 ±2.63 and 3. 10 ±1.65, all P <0. 01),while there were no difference compared with gestational trophoblastic neoplasms (6. 42 ±2. 68, P=0. 113).The level of PPM1A expression was highest in normal chorionic villus, and decreased gradually in hydatidiform mole (non-deteriorative and deteriorative) and gestational trophoblastic neoplasms (6. 30 ±2. 98, 4. 93 ± 2. 50, 4. 43 ± 2. 04 and 3. 33 ± 2. 06, all P < 0. 01); the level of PPM1A expression in deteriorative hydatidiform mole was significantly lower than that in non-deteriorative hydatidiform mole (P=0.001). The expression of LMP2 protein was correlated to theca lutein ovarian cyst, the expression of PPM1A protein was related with uterine size (P < 0. 05) . While, there was no correlation between the expressions of the two proteins (P >0. 05). Conclusions High expression of LMP2 and low expression of PPM1A might play an important role in the motility and invasiveness of trophohlast cells and malignant transformation of hydatidiform mole. Testing the expression of LMP2 and PPM1A in hydatidiform mole tissues of initial uterine evacuation might be have some reference significance in judging outcomes of hydatidiform mole.
3.Discussion about the innovative ways of scientific research management according to the current situation and existed problems of research project at hospital level in specialized hospitals
Yanqiong GU ; Qian ZHOU ; Guanghua WANG ; Xing CHENG ; Yanting WU ; Xiaoping WAN
Chinese Journal of Medical Science Research Management 2017;30(1):35-37,51
To analyze the potential limitations of hospital-level research projects management by summarizing its performance status from 2008 to 2011,including but not limited to lack of time for conducting research,insufficient financial funds,inadequate funding application,inadequate supervision.Thus,since 2014,our hospital has adopted some new measurements for projects management,including full-time research,hierarchical management,full mobilization,the establishment of reward and punishment measures,which significantly improved the quality of hospital-level research projects,and the rate of longitudinal follow-up project,research enthusiasm of medical staff,and sustainable development of hospital science and technology.
4.Therapeutic effect of deoxyribonucleotidum on acute viral myocarditis.
Zhi-huan ZENG ; Da LEI ; Wan-xing ZHOU
Journal of Southern Medical University 2006;26(10):1498-1499
OBJECTIVETo evaluate the therapeutic efficacy of deoxyribonucleotidum in treatment of acute viral myocarditis.
METHODSEighty-eight patients with acute viral myocarditis were randomized equally into therapeutic group and control group. Patients in the control group were treated with routine treatment and those in the therapeutic group were given deoxyribonucleotidum in addition to routine treatment. After 4 weeks, the total efficacy rate and median time of symptom disappearance were compared between the two groups.
RESULTSThe total efficacy rate in the control and therapeutic groups was 79.54% and 95.45% (P=0.049), and the median time of symptom disappearance was 9.5 days and 6.5 days, respectively (P=0.035). Hypotension and mild dizziness were found in 2 patients in the therapeutic group without other severe side effects.
CONCLUSIONDeoxyribonucleotidum can improve the therapeutic effect for acute viral myocarditis.
Adolescent ; Adult ; Deoxyribonucleotides ; therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Myocarditis ; drug therapy ; Treatment Outcome ; Virus Diseases ; drug therapy
5.Protective effect of Shenxiong injection on cerebral ischemia-reperfusion injury of rats.
Xing-Yu WANG ; Yu-Yan ZHANG ; Hai-Tong WAN ; Tao ZHAO ; Wei FU ; Hui-Fen ZHOU ; Peng ZHOU ; Ze-Feng WANG ; Jie-Hong YANG
China Journal of Chinese Materia Medica 2014;39(3):503-506
OBJECTIVETo study the protective effect of Shenxiong injection on the cerebral ischemia-reperfusion injury of senile rats.
METHODTotally 108 Sprague-Dawley (SD) rats were randomly divided into the sham operation group, the model group, the Ni-modipine group and Shenxiong injection groups (low, middle, and high doses). The rat brain ischemia-reperfusion model was established by the middle cerebral artery occlusion (MCAO) method in rats, in order to observe the effect of Shenxiong injection on neurological score and brain infarct volume of rats with cerebral ischemia-reperfusion injury, and determine the contents of NOS, NO, SOD, MDA and LDH in brain tissues. The contents of TNF-alpha and IL-1beta levels in brain tissues were measured by enzyme-linked immunosorbent assay (ELISA) method.
RESULTShenxiong injection could significantly decrease neurological score, injury degree of brain tissues and brain infarct volume of rats with cerebral ischemia-reperfusion injury, increase the vigor of SOD, decrease the levels of MDA, NO, NOS and LDH, and inhibit IL-1beta and TNF-alpha expressions.
CONCLUSIONShenxiong injection has the obvious protective effect on the brain ischemia-reperfusion injury in rats. Its mechanism may be related to the improvement of neurological function, the reduction of free radical injury, and the inhibition of inflammation factor expression.
Animals ; Brain ; blood supply ; drug effects ; metabolism ; Brain Ischemia ; complications ; Drugs, Chinese Herbal ; administration & dosage ; pharmacology ; therapeutic use ; Injections ; L-Lactate Dehydrogenase ; metabolism ; Male ; Malondialdehyde ; metabolism ; Nitric Oxide ; metabolism ; Nitric Oxide Synthase ; metabolism ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury ; complications ; drug therapy ; enzymology ; metabolism ; Superoxide Dismutase ; metabolism
6.Preliminary report of using cardiopulmonary exercise testing guide exercise rehabilitation in patients with chronic heart failure.
Yan-ling LIU ; Xing-guo SUN ; Hua GAO ; Zhen-ying ZHANG ; Jing FENG ; Li-qing JIANG ; Jian ZHANG ; Jia-ning XI ; Jing-min ZHOU ; Wan-gang GE
Chinese Journal of Applied Physiology 2015;31(4):374-377
OBJECTIVEThe exercise rehabilitation in patient with chronic heart failure (CHF) is standard clinical practice, but it is rare using CardioPulmonary Exercise Testing (CPET) guide to prescribe exercise rehabilitation in China.
METHODSWe performed symptom limited maximal CPET in 10 patients with CHF, randomly divided into two groups: 5 patients as control without exercise and 5 exercise patients used Δ50%W intensity to exercise 30 min/d, 5 d/w, x12 w. Before and after 12 w rehabilitation, we evaluated functions.
RESULTSThere were no significant difference between two groups patients (P > 0.05). The exercise duration was increased from 8 min to 23 min after rehabilitation (P < 0.001); distance 6 minutes walking was increased from 394 m to 470 m (P < 0.05); score of Minnesota quality of life was decreased from 25 to 3 in exercise group (P < 0.01). However, there were nosignificant changes in control group (P>0.05) and their changes were smaller than those in exercise group (P < 0.01).
CONCLUSIONThe CPET guiding exercise rehabilitation is safe and effective for patients with CHF.
China ; Chronic Disease ; Exercise Test ; Exercise Therapy ; Heart Failure ; therapy ; Humans ; Quality of Life ; Walking
7.A study on the supervision index of food safety for large-scale outdoor activities
Dong-Hong ZHANG ; Yi SHEN ; Xing-Qin ZHANG ; Qin ZHOU ; Xiao-Wan GU ; Qing YANG
Journal of Preventive Medicine 2016;28(5):465-468
Objective Todiscussandestablishaquantitativesupervisionindexoffoodsafetyforlarge-scaleoutdoor activities,andtoprovidescientificbasisforthestudyofsupervisionsystemforfoodsafety.Methods Delphiexpert consultation method was used to establish the supervision index system of food safety for large-scale outdoor activities,and the weight of the indicators were determined.Indexes were screened based on 5 -point liker scale,and weight was determinedonthebasisofproportionmethod.Results Theaverageserviceyearofthe21expertswere21.52±9.05.The response rates were both 1 00% in two rounds of consultation,and the average authoritative coefficients were 0.78 ±0.03 and 0.79 ±0.03,respectively.Kendall's coefficient was 0.46 in the first round and 0.51 in the second round.The secondary indicators was 0.38 in the first round and 0.33 in second round (P <0.01 ).A total of 6 primary and 32 secondary indicators were identified and at the same time their weights were measured.The alert line was 75 .Conclusion Foodsafetyriskoflarge-scaleoutdooractivitieswassignificantlyhigherthanthatoflarge-scaleindooractivities.The study of quantitative supervision index system of food safety for large-scale outdoor is practical.It can provide scientific evidence and technical support for the supervision of food safety.
8.Protective effect of sodium tanshinone IIA sulfonate on injury of small intestine in rats with sepsis and its mechanism.
Wei ZHU ; Qing LU ; Hua-wen CHEN ; Jun FENG ; Lei WAN ; Dai-xing ZHOU
Chinese journal of integrative medicine 2012;18(7):496-501
OBJECTIVETo explore the protective effect of sodium tanshinone IIA sulfonate (STS) on small: intestine injury in rats with sepsis and its possible mechanism.
METHODSAccording to a random number table, 24 Tats were randomly divided into 3 groups: sham operation group (sham group), sepsis model group (model group) and STS treatment group (STS group), with 8 Tats in each group. A rat model of sepsis was induced by cecal ligation and puncture (CLP) for 5 h. STS (1 mg/kg) was slowly injected through the right external jugular vein after CLP. The histopathologic changes in the intestine tissue were observed under a light microscope, and the intestinal epithelial cell apoptosis was evaluated by terminal deoxynucleoddyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) method. The expressions of Bcl-2, Bax and nuclear factor κB (NF-κB) p65 in the intestinal tissue was determined by Western blot. The levels of tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) in the intestinal tissue were determined using enzyme-linked immuno-sorbent assay (ELISA).
RESULTSObvious injuries were observed in the intestinal tissue in the CLP group compared with the sham group. The expression of NF-κB p65 and the levels of TNF-α and IL-6 were up-regulated after CLP, the apoptosis of intestinal epithelial cells was increased after CLP, and the ratio of Bcl-2 to Bax was decreased. STS post-treatment could attenuate the injury on the intestinal tissue induced by CLP, decrease the apoptosis of intestinal treatment epithelial cells and the levels of NF-κB p65, TNF-α and IL-6, and increase the ratio of Bcl-2 to Bax.
CONCLUSIONSTS can protect the small intestine in rats with sepsis, and the mechanism may be associated with the inhibition of intestinal epithelial apoptosis and the reduction of activation of inflammatory cytokines.
Animals ; Apoptosis ; drug effects ; Interleukin-6 ; metabolism ; Intestine, Small ; drug effects ; injuries ; metabolism ; pathology ; Male ; Phenanthrenes ; pharmacology ; therapeutic use ; Protective Agents ; pharmacology ; therapeutic use ; Rats ; Rats, Wistar ; Sepsis ; drug therapy ; pathology ; Transcription Factor RelA ; metabolism ; Tumor Necrosis Factor-alpha ; metabolism ; bcl-2-Associated X Protein ; metabolism
9.Effects of electroacupuncture at "Fenglong" (ST 40) on NO, ET and CGRP levels in the rat with hyperlipidemia.
Li ZHOU ; Wen-jun WAN ; Ling-guang LIU ; Xuan LI ; Hong-xing ZHANG ; Tang-fa ZHANG
Chinese Acupuncture & Moxibustion 2008;28(1):57-60
OBJECTIVETo probe the regulative effect of electroacupuncture (EA) at "Fenglong" (ST 40) on blood lipids in hyperlipidemia (HLP) rats and the mechanism.
METHODSEighty Wistar rats were randomly divided into a normal group (fed with basal forage), a model group (fed with high fat forage), an EA group (fed with high fat forage + EA treatment), a western medicine group (fed with high fat forage + Pravastatin sodium). Contents of serum total cholesterol (TC), triacylglycerol (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), endothelin (ET), nitric oxide (NO) and calcitonin gene-related peptide (CGRP) were determined before and after treatment.
RESULTSCompared with the normal group, the body weight, levels of TC, TG, LDL-C and ET were significantly elevated (P < 0.05, P < 0.01) and the levels of HDL-C, NO and CGRP were significantly decreased (P < 0.05) in the model group; compared with the model group, the body weight, levels of TC, TG and LDL-C were significantly decreased (P < 0.01) and the levels of NO and CGRP were significantly increased in the western medicine group and the EA group (P < 0.01, P < 0.05); compared with the EA group, HDL-C level significantly increased in the western medicine group (P < 0.01), and ET level decreased in the EA group and the western medicine group with no significant difference between the two groups (P > 0.05).
CONCLUSIONBoth EA and Pravastatin sodium have better benign regulative effects on TC, TG, LDL-C, NO and CGRP and can decrease ET level to a certain extent in the rat of hyperlipidemia.
Acupuncture Points ; Animals ; Calcitonin Gene-Related Peptide ; blood ; Cholesterol, HDL ; blood ; Cholesterol, LDL ; blood ; Electroacupuncture ; Endothelins ; blood ; Hyperlipidemias ; blood ; therapy ; Male ; Nitric Oxide ; blood ; Rats ; Rats, Wistar
10.Retrospective observation of curative effects on MDS refractory anemia with combination of all-trans retinoic acid, 1, 25-dihydroxyvitamin D3 and androgen.
Fu-Ling ZHOU ; Wang-Gang ZHANG ; Xing-Mei CAO ; Yin-Xia CHEN ; Ai-Li HE ; Jie LIU ; Wan-Hong ZHAO ; Xiao-Rong MA ; Gang CHEN
Journal of Experimental Hematology 2005;13(5):861-866
This study was aimed to examine whether a combination of all-trans retinoic acid (ATRA), 1, 25-dihydroxyvitamin D(3) and androgen possesses the therapeutic value for the MDS-refractory anemia (MDS-RA), and to analyze the mechanisms in detail. 62 cases receiving a scheme of combination of ATRA, 1, 25-dihydroxyvitamin D(3) and androgen (group A) were monitored. The remaining 33 cases (group B) were provided with vitamin supplementation, chalybeate drugs, and one or two of the combination. Bone marrow aspiration and biopsy were performed for collecting the specimens at the baseline and afterwards. The conditions of the patients were monitored by means of weekly complete blood counts and the monthly examination, including toxicity test, physical examination, electrocardiography, and biochemistry panel. The results showed that after treating for 8 weeks in group A, 4 out of 62 patients showed complete remission and 12 patients showed partial remission according to the defined response criteria, and 43 patients (69.35%) showed hematological improvement (HI). The further treatment for 16 out of 62 patients (25.81%), 13 failures (10 deaths, 2 RAEB and 1 RAEB-T) and 3 transformations (M(2), M(3), M(5)) with a median survival interval of 26.25 months, were observed and interrupted for some reasons. However, partial remission was observed only in 3 patients in group B, and HI amounted to 51.51%. Furthermore, the disease progression was observed in 12 out of 33 patients (36.36%) with a median survival interval of 16 months, 9 failures (including 6 deaths, 2 RAEB and 1 RAEB-T) and 3 transformations (M(2), M(3), M(4)). The overall ratios of survival for 3 and 5 years in group A, which received the combination, reached to 69.24% and 53.72% respectively, in comparison with 52.23% and 31.34% in the patients of group B (log-rank, P = 0.016). The following requirements, if were met, would be significant for prognosis: the combination regiment, no transformation, children, no complication, female, 90-120 g/L of hemoglobin concentration, normal cellular bone marrow and uni-cytopenias (P < 0.05). Moreover, Cox regression showed that therapy, transformation and age are all the independent factors (P < 0.05). It is concluded that the combination of above mentioned 3 drugs may be effective and safe treatment for the patients with MDS-RA. Its relevant mechanisms can be involved in the combination, that elicits a wide range of pharmacological effects, such as differentiation, anti-tumor-promotion, anti-apoptosis, anti-angiogenesis, anti-cachexia and immunoregulation.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Androgens
;
administration & dosage
;
therapeutic use
;
Anemia, Refractory
;
blood
;
drug therapy
;
Blood Cell Count
;
Calcitriol
;
administration & dosage
;
therapeutic use
;
Child
;
Child, Preschool
;
Drug Therapy, Combination
;
Female
;
Humans
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
blood
;
drug therapy
;
Retrospective Studies
;
Survival Analysis
;
Time Factors
;
Treatment Outcome
;
Tretinoin
;
administration & dosage
;
therapeutic use